Christopher Richard Anzalone
Chief Executive Officer at Arrowhead Pharmaceuticals · 28 reported transactions in 1 company · latest trade Jan 2, 2026
Their trades
Sold | Jan 2, 2026 | Jan 2, 2026 close $67.79 → Oct 29, 2026 close $59.75. S&P 500 +12.6% over the same days. | ||
Sold | Jan 2, 2026 | Jan 2, 2026 close $67.79 → Oct 29, 2026 close $59.75. S&P 500 +12.6% over the same days. | ||
Sold | Dec 29, 2025 | Dec 29, 2025 close $69.62 → Oct 29, 2026 close $59.75. S&P 500 +11.8% over the same days. | ||
Sold | Dec 29, 2025 | Dec 29, 2025 close $69.62 → Oct 29, 2026 close $59.75. S&P 500 +11.8% over the same days. | ||
Sold | Dec 22, 2025 | Dec 22, 2025 close $69.00 → Oct 29, 2026 close $59.75. S&P 500 +12.3% over the same days. | ||
Sold | Dec 22, 2025 | Dec 22, 2025 close $69.00 → Oct 29, 2026 close $59.75. S&P 500 +12.3% over the same days. | ||
Sold | Dec 19, 2025 | Dec 19, 2025 close $68.16 → Oct 29, 2026 close $59.75. S&P 500 +13.0% over the same days. | ||
Sold | Dec 19, 2025 | Dec 19, 2025 close $68.16 → Oct 29, 2026 close $59.75. S&P 500 +13.0% over the same days. |
$383.1K
Jan 2, 2026 close $67.79 → Oct 29, 2026 close $59.75. S&P 500 +12.6% over the same days.
$488.6K
Jan 2, 2026 close $67.79 → Oct 29, 2026 close $59.75. S&P 500 +12.6% over the same days.
$1.14M
Dec 29, 2025 close $69.62 → Oct 29, 2026 close $59.75. S&P 500 +11.8% over the same days.
$2.44M
Dec 29, 2025 close $69.62 → Oct 29, 2026 close $59.75. S&P 500 +11.8% over the same days.
$177.2K
Dec 22, 2025 close $69.00 → Oct 29, 2026 close $59.75. S&P 500 +12.3% over the same days.
$684.1K
Dec 22, 2025 close $69.00 → Oct 29, 2026 close $59.75. S&P 500 +12.3% over the same days.
$90.3K
Dec 19, 2025 close $68.16 → Oct 29, 2026 close $59.75. S&P 500 +13.0% over the same days.
$554.1K
Dec 19, 2025 close $68.16 → Oct 29, 2026 close $59.75. S&P 500 +13.0% over the same days.